BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 18667373)

  • 1. Lights and shadows of the tumoral marker CA-125 in ovarian cancer.
    Sánchez Muñoz A; González Martín A; Mendiola Fernández C
    Clin Transl Oncol; 2008 Aug; 10(8):449-52. PubMed ID: 18667373
    [No Abstract]   [Full Text] [Related]  

  • 2. Early detection of ovarian cancer: promise and reality.
    Bast RC; Urban N; Shridhar V; Smith D; Zhang Z; Skates S; Lu K; Liu J; Fishman D; Mills G
    Cancer Treat Res; 2002; 107():61-97. PubMed ID: 11775462
    [No Abstract]   [Full Text] [Related]  

  • 3. How to overcome the disturbing effects of human anti-mouse antibodies (HAMA) on in vitro assays.
    Oltrogge JB; Baum RP; Lema KN; Donnerstag B; Hör G
    Int J Biol Markers; 1997; 12(1):15-7. PubMed ID: 9176712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of ultrasound and tumour markers in the early detection of ovarian cancer.
    Oram DH; Jeyarajah AR
    Br J Obstet Gynaecol; 1994 Nov; 101(11):939-45. PubMed ID: 7999723
    [No Abstract]   [Full Text] [Related]  

  • 5. [Usefulness of CA-125 antigen for monitoring neoplastic processes in patients with ovarian tumors].
    Kwaśniewska-Rokicińska C; Bartnikowa W; Koterbicka A; Deja R
    Ginekol Pol; 1994 Mar; 65(3):136-41. PubMed ID: 8001848
    [No Abstract]   [Full Text] [Related]  

  • 6. [CA-125 antigen].
    Zakrzewska I
    Postepy Hig Med Dosw; 2002; 56(1):29-38. PubMed ID: 11987487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limitations to the use of the CA-125 antigen level in ovarian cancer.
    Markman M
    Curr Oncol Rep; 2003 Jul; 5(4):263-4. PubMed ID: 12781066
    [No Abstract]   [Full Text] [Related]  

  • 8. [The role of tumor marker CA 125 in the treatment of ovarian cancer].
    Porsbjerg CM; Sørensen JB; Lund BA
    Ugeskr Laeger; 1998 Feb; 160(7):995-1000. PubMed ID: 9477746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum markers as prognostic factors in epithelial ovarian cancer: an overview.
    Maggino T; Gadducci A
    Eur J Gynaecol Oncol; 2000; 21(1):64-9. PubMed ID: 10726623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Markers supplementing CA 125 in ovarian cancer.
    Stenman UH; Alfthan H; Vartiainen J; Lehtovirta P
    Ann Med; 1995 Feb; 27(1):115-20. PubMed ID: 7741989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ovarian cancer as a chronic disease: a new treatment paradigm. Highlights of a roundtable discussion.
    Spriggs DR
    Cancer Control; 2001; 8(6 Suppl 1):5-7; discussion 8-18. PubMed ID: 11910332
    [No Abstract]   [Full Text] [Related]  

  • 12. [The value of CA 125 levels in serum, peritoneal fluid and tumor in women with ovarian cancer].
    Markowska J; Wilkoszarska J
    Ginekol Pol; 1996 Jul; 67(7):352-6. PubMed ID: 9138997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis of ovarian cancer.
    Sundar S; Neal RD; Kehoe S
    BMJ; 2015 Sep; 351():h4443. PubMed ID: 26328593
    [No Abstract]   [Full Text] [Related]  

  • 14. [The value of CA125 and LDH assays in assisting diagnosis of epithelial ovarian carcinoma].
    Qie M; Peng Z; Cao Z; Tang Q; He B
    Hua Xi Yi Ke Da Xue Xue Bao; 1996 Sep; 27(3):310-3. PubMed ID: 9389070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [CA 125 in epithelial ovarian cancer].
    Mogensen O
    Ugeskr Laeger; 1998 May; 160(22):3236. PubMed ID: 9621807
    [No Abstract]   [Full Text] [Related]  

  • 16. New technologies for the identification of markers for early detection of ovarian cancer.
    Bandera CA; Ye B; Mok SC
    Curr Opin Obstet Gynecol; 2003 Feb; 15(1):51-5. PubMed ID: 12544502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor markers in the management of patients with ovarian cancer.
    Tuxen MK; Sölétormos G; Dombernowsky P
    Cancer Treat Rev; 1995 May; 21(3):215-45. PubMed ID: 7656266
    [No Abstract]   [Full Text] [Related]  

  • 18. Ovarian cancer: the role of functional imaging as an end point in clinical trials.
    Sala E; DeSouza N; Lee SI; Atri M; Hricak H;
    Int J Gynecol Cancer; 2010 Aug; 20(6):971-8. PubMed ID: 20683404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ovarian cancers and CA 125 in 2006].
    Lambaudie E; Collinet P; Vinatier D
    Gynecol Obstet Fertil; 2006 Mar; 34(3):254-7. PubMed ID: 16529967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CA 125 in biological fluids.
    Molina R; Filella X; Jo J; Agusti C; Ballesta AM
    Int J Biol Markers; 1998; 13(4):224-30. PubMed ID: 10228906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.